Logo image of ARR

ARMOUR RESIDENTIAL REIT INC (ARR) Stock Fundamental Analysis

NYSE:ARR - New York Stock Exchange, Inc. - US0423157058 - REIT - Currency: USD

18.89  -0.05 (-0.26%)

After market: 18.8799 -0.01 (-0.05%)

Fundamental Rating

4

Taking everything into account, ARR scores 4 out of 10 in our fundamental rating. ARR was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. ARR has a bad profitability rating. Also its financial health evaluation is rather negative. ARR is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ARR had positive earnings in the past year.
ARR had a positive operating cash flow in the past year.
In the past 5 years ARR reported 4 times negative net income.
Of the past 5 years ARR 4 years had a positive operating cash flow.
ARR Yearly Net Income VS EBIT VS OCF VS FCFARR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

ARR has a Return On Assets of -0.19%. This is in the lower half of the industry: ARR underperforms 62.50% of its industry peers.
Looking at the Return On Equity, with a value of -1.94%, ARR is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
ROA -0.19%
ROE -1.94%
ROIC N/A
ROA(3y)-1.14%
ROA(5y)-1.48%
ROE(3y)-9.99%
ROE(5y)-10.72%
ROIC(3y)N/A
ROIC(5y)N/A
ARR Yearly ROA, ROE, ROICARR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ARR's Gross Margin of 1.09% is on the low side compared to the rest of the industry. ARR is outperformed by 90.63% of its industry peers.
In the last couple of years the Gross Margin of ARR has declined.
The Profit Margin and Operating Margin are not available for ARR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-71.79%
GM growth 5YN/A
ARR Yearly Profit, Operating, Gross MarginsARR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1

2. Health

2.1 Basic Checks

The number of shares outstanding for ARR has been increased compared to 1 year ago.
The number of shares outstanding for ARR has been increased compared to 5 years ago.
ARR has a worse debt/assets ratio than last year.
ARR Yearly Shares OutstandingARR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ARR Yearly Total Debt VS Total AssetsARR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of -1.06, we must say that ARR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.06, ARR is not doing good in the industry: 95.31% of the companies in the same industry are doing better.
The Debt to FCF ratio of ARR is 40.98, which is on the high side as it means it would take ARR, 40.98 years of fcf income to pay off all of its debts.
ARR has a Debt to FCF ratio of 40.98. This is in the better half of the industry: ARR outperforms 62.50% of its industry peers.
A Debt/Equity ratio of 7.87 is on the high side and indicates that ARR has dependencies on debt financing.
ARR has a worse Debt to Equity ratio (7.87) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.87
Debt/FCF 40.98
Altman-Z -1.06
ROIC/WACCN/A
WACCN/A
ARR Yearly LT Debt VS Equity VS FCFARR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

ARR has a Current Ratio of 0.01. This is a bad value and indicates that ARR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.01, ARR is doing worse than 98.44% of the companies in the same industry.
ARR has a Quick Ratio of 0.01. This is a bad value and indicates that ARR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.01, ARR is doing worse than 98.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ARR Yearly Current Assets VS Current LiabilitesARR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The earnings per share for ARR have decreased strongly by -20.86% in the last year.
Measured over the past years, ARR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.48% on average per year.
Looking at the last year, ARR shows a quite strong growth in Revenue. The Revenue has grown by 12.36% in the last year.
ARR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.97% yearly.
EPS 1Y (TTM)-20.86%
EPS 3Y56.5%
EPS 5Y9.48%
EPS Q2Q%-27.1%
Revenue 1Y (TTM)12.36%
Revenue growth 3Y114.12%
Revenue growth 5Y48.97%
Sales Q2Q%118.97%

3.2 Future

Based on estimates for the next years, ARR will show a small growth in Earnings Per Share. The EPS will grow by 7.28% on average per year.
The Revenue is expected to grow by 136.98% on average over the next years. This is a very strong growth
EPS Next Y9.23%
EPS Next 2Y7.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year292.05%
Revenue Next 2Y136.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARR Yearly Revenue VS EstimatesARR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 200M 400M
ARR Yearly EPS VS EstimatesARR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15 20

8

4. Valuation

4.1 Price/Earnings Ratio

ARR is valuated cheaply with a Price/Earnings ratio of 5.13.
Compared to the rest of the industry, the Price/Earnings ratio of ARR indicates a rather cheap valuation: ARR is cheaper than 96.88% of the companies listed in the same industry.
ARR is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 4.70 indicates a rather cheap valuation of ARR.
98.44% of the companies in the same industry are more expensive than ARR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ARR to the average of the S&P500 Index (22.68), we can say ARR is valued rather cheaply.
Industry RankSector Rank
PE 5.13
Fwd PE 4.7
ARR Price Earnings VS Forward Price EarningsARR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ARR is valued cheaply inside the industry as 96.88% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.03
EV/EBITDA N/A
ARR Per share dataARR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.56
PEG (5Y)0.54
EPS Next 2Y7.28%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 15.21%, ARR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 12.96, ARR pays a bit more dividend than its industry peers.
ARR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 15.21%

5.2 History

The dividend of ARR has a limited annual growth rate of 1.50%.
ARR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)1.5%
Div Incr Years0
Div Non Decr Years0
ARR Yearly Dividends per shareARR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

5.3 Sustainability

The earnings of ARR are negative and hence is the payout ratio. ARR will probably not be able to sustain this dividend level.
ARR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-617.73%
EPS Next 2Y7.28%
EPS Next 3YN/A
ARR Yearly Income VS Free CF VS DividendARR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

ARMOUR RESIDENTIAL REIT INC

NYSE:ARR (2/21/2025, 8:04:00 PM)

After market: 18.8799 -0.01 (-0.05%)

18.89

-0.05 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners44.51%
Inst Owner Change24.86%
Ins Owners0.24%
Ins Owner Change4.35%
Market Cap1.05B
Analysts50.77
Price Target20.4 (7.99%)
Short Float %5.32%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 15.21%
Yearly Dividend2.93
Dividend Growth(5Y)1.5%
DP-617.73%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2025-03-17 (0.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.52%
Min EPS beat(2)-21.46%
Max EPS beat(2)0.42%
EPS beat(4)2
Avg EPS beat(4)-7.15%
Min EPS beat(4)-21.46%
Max EPS beat(4)8.45%
EPS beat(8)3
Avg EPS beat(8)-4.55%
EPS beat(12)6
Avg EPS beat(12)-1.29%
EPS beat(16)6
Avg EPS beat(16)-4.37%
Revenue beat(2)0
Avg Revenue beat(2)-85.01%
Min Revenue beat(2)-96.41%
Max Revenue beat(2)-73.6%
Revenue beat(4)0
Avg Revenue beat(4)-87.26%
Min Revenue beat(4)-96.41%
Max Revenue beat(4)-73.6%
Revenue beat(8)0
Avg Revenue beat(8)-85.65%
Revenue beat(12)1
Avg Revenue beat(12)-120.31%
Revenue beat(16)3
Avg Revenue beat(16)-99.28%
PT rev (1m)-0.83%
PT rev (3m)-2.44%
EPS NQ rev (1m)-2.32%
EPS NQ rev (3m)-2.32%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)28.83%
Revenue NQ rev (3m)27.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-62.94%
Valuation
Industry RankSector Rank
PE 5.13
Fwd PE 4.7
P/S 1.87
P/FCF 4.03
P/OCF 4.03
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)3.68
EY19.48%
EPS(NY)4.02
Fwd EY21.28%
FCF(TTM)4.69
FCFY24.82%
OCF(TTM)4.69
OCFY24.82%
SpS10.1
BVpS24.42
TBVpS24.42
PEG (NY)0.56
PEG (5Y)0.54
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -1.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.09%
FCFM 46.41%
ROA(3y)-1.14%
ROA(5y)-1.48%
ROE(3y)-9.99%
ROE(5y)-10.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-71.79%
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 7.87
Debt/FCF 40.98
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.06
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.86%
EPS 3Y56.5%
EPS 5Y9.48%
EPS Q2Q%-27.1%
EPS Next Y9.23%
EPS Next 2Y7.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.36%
Revenue growth 3Y114.12%
Revenue growth 5Y48.97%
Sales Q2Q%118.97%
Revenue Next Year292.05%
Revenue Next 2Y136.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y96.86%
FCF growth 3Y181.37%
FCF growth 5YN/A
OCF growth 1Y96.86%
OCF growth 3Y181.37%
OCF growth 5YN/A